Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

blank

 

Recent News and Articles on the Keywords: alzheimer's disease + mental function + alzheimers  Related to the article below (Last Update: 5/5/2008)

Depression raises risk of Alzheimer's and dementia
Canada.com, Canada - May 3, 2008
Men with a history of experiencing symptoms of depression may be twice as likely to develop dementia or Alzheimer's disease as men who don't display these ...
Systems Biology in the Study of Neurological Disorders: Focus on ...
RedOrbit, TX - Apr 30, 2008
By comparing cDNA patterns in the brains of people with a disease (eg, dementia) with those of people without the disease (eg, normal mental function), ...
Tarenflurbil Trial Encouraging For Mild Alzheimer's Disease Patients
Medical News Today, UK - Apr 30, 2008
Measurements from the CDR-sb indicated that tarenflurbil resulted in a 36% slower pace of decline in global function. Tarenflurbil, however, had no ...
Investigational Drug Slows Functional Decline in Early Alzheimer's
MedPage Today, NJ - Apr 29, 2008
... moderate Alzheimer's disease, defined by scores of 15 to 19 on the Mini-Mental State Exam. However, during the first year of treatment, global function ...
Pfizer's Lipitor Failed to Slow Alzheimer's Disease in Study
Bloomberg - Apr 17, 2008
The results clash with previous research that showed high cholesterol raises the risk of Alzheimer's disease, an inexorable loss of memory and function that ...PFE
Alzheimer's disease To have and have not
Economist, UK - Apr 17, 2008
This points to the idea that the tangles and plaques may not directly impair brain function after all. Something else may cause the mental decline. ...
Tarenflurbil slows decline of mild Alzheimer's patients in phase ...
Checkbiotech.org (press release), Switzerland - Apr 29, 2008
Patients with mild Alzheimer's disease (AD) who take 800mg of tarenflurbil twice daily show less decline in functional ability than those taking placebo. ...
Alzheimer's Patients On Experimental Drug Showed Improved Mental ...
Medical News Today, UK - Apr 18, 2008
Also, at the six month point, the patients on the drug showed significantly better function on all five aspects of the disease than they did at the start of ...
Drug May Slow Alzheimer?s Decline
WebMD - Apr 29, 2008
By Jennifer Warner April 29, 2008 -- An experimental new drug may help people with mild Alzheimer's disease by slowing the functional decline of the disease ...
Ban of the batch
Business Standard, India - May 3, 2008
Members of well-functioning groups tend to live longer and are less likely to suffer depression, mental illness, Alzheimer's disease ? even the common cold. ...
Source: Google News

… , placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group -
SL Rogers - Neurology, 1998 - AAN Enterprises
... the cognitive portion of the Alzheimer's Disease Assessment Scale ... plus), with the
Mini-Mental State Examination ... Cognitive function, as measured by the ADAS-cog ...

The cholinergic hypothesis of Alzheimer's disease: a review of progress -
PT Francis, AM Palmer, M Snape, GK Wilcock - British Medical Journal, 1999 - jnnp.bmj.com
... CIBIC measures patients' global function in terms of ... of the patient with Alzheimer's
disease (for example ... further assessment, the mini mental state examination ...

Memory function in very early Alzheimer's disease -
RC Petersen - Neurology, 1994 - AAN Enterprises
... from the Mayo Clinic Alzheimer's Disease Patient Registry ... that included measures
of memory function, verbal and ... subjects on the Mini-Mental State Examination ...

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease -
JC Morris - Neurology, 1998 - AAN Enterprises
... Patients had Mini-Mental State Examination (MMSE ... efficacy variables were the Alzheimer's
Disease Assessment Scale ... the cognitive and global function, but also the ...

Brain Choline Acetyltransferase and Mental Function in Alzheimer Disease -
DS Baskin, JL Browning, FJ Pirozzolo, S Korporaal, … - Archives of Neurology, 1999 - Am Med Assoc
... Brain Choline Acetyltransferase and Mental Function in Alzheimer Disease
David S. Baskin, MD ; Jeffrey L. Browning, MS ; Francis ...

Alzheimer's disease: A study of epidemiological aspects -
A Heyman, WE Wilkinson, JA Stafford, MJ Helms, AH … - Annals of Neurology, 1984 - doi.wiley.com
... and controls with a history of severe head injuries had ap- parently regained normal
mental function after the ... Heyman et al: Alzheimer?s Disease 337 Page 4. ...

… galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled … -
GK Wilcock? - BMJ, 2000 - pubmedcentral.nih.gov
... Improvements in cognitive function from baseline in the ... cognitive subscale of the
Alzheimer's disease assessment scale ... score on mini-mental state examination ...

Apolipoprotein E and Alzheimer's Disease -
WJ Strittmatter, AD Roses - Annual Reviews in Neuroscience, 1996 - Annual Reviews
... by progressive dementia, which is the diffuse deterioration of mental function. ...
Communicative Diseases and Stroke and the Alzheimer?s Disease and Related ...

Sleep, EEG and mental function changes in senile dementia of the Alzheimer's type -
PN Prinz, PP Vitaliano, MV Vitiello, J Bokan, M … - Neurobiology of Aging, 1982 - Elsevier
... Alz heimer's type degenerative changes are associated with mental function deficits. ...
life expectancy as well as stage of the disease of Alzheimer's (but not ...

… in Annual Mini-Mental State Examination Score in Patients With Probable Alzheimer Disease A … -
CM Clark, L Sheppard, GG Fillenbaum, D Galasko, JC … - Archives of Neurology, 1999 - Am Med Assoc
... Conclusions Although the Mini-Mental State Examination ... assess level of cognitive
function, it has ... measuring the progression of Alzheimer disease in individual ...

Source: Google Scholar

Can Mental Function be Restored in Alzheimer's Disease?

An animal experiment raises the hope of future treatment that might restore at least a portion of mental function lost to Alzheimer's disease.

Mice genetically engineered to suffer Alzheimer's-like memory loss regained some of that memory when the disabling gene was turned off, according to a report in the July 15 issue of Science by researchers at the University of Minnesota.

The restoration of lost cognitive function is a revolutionary idea, the researchers say, because so far studies have centered on slowing the loss of mental function in Alzheimer's patients, not reversing it.

The mice in the experiment suffered a major loss of neurons, the brain cells that drive thinking. That loss was not restored, said study author Dr. Karen Ashe, a professor of neurology. However, she said the mice's memory ability nevertheless improved.

"That implies that the remaining neurons were functioning improperly," Ashe said. "If we discover a way to remove the molecules affecting the remaining neurons, Alzheimer's patients who have lost neurons would regain their ability to learn," she speculated.

Ashe pointed to one molecule as a prime suspect -- some abnormal form of tau, a protein that plays a key role in structuring the brain.

The villainous tau molecule is not the one found in the fibrous tangles that are one of the two visible features of Alzheimer's disease, Ashe added. Mice recovered their memory even though the number of tangles in their brains increased, she pointed out.

"These neurofibrillary tangles -- one of the defining features of Alzheimer's disease -- are not the cause of the memory problems," she said.

Therapy aimed at the other major feature of the disease, toxic deposits of a protein called beta-amyloid, is just now moving into the clinic, said William Thies, vice president for medical and scientific affairs at the Alzheimer's Association. That therapy developed from animal experiments similar to the one reported by Ashe and her colleagues, he noted.

Her team "have produced a tool with which people can begin to explore whether limiting tau can be a good endpoint," Thies said.

Mice in the study were trained to swim to a submerged platform in a pool of water. They lost the ability to find the platform when the damaging gene was in action and regained it when the gene was turned off -- a surprising gain in memory.

"Many of us have thought that the brains of Alzheimer's patients have live neurons, dead ones and sick ones," Thies said. "If you remove whatever is irritating the sick ones, they can get better."

While the new study centered on tau, "maybe the ultimate treatment is something that reduces the accumulation of both amyloid and tau," Thies said.

The form of tau that may become a target for treatment is unknown, Ashe said. "Maybe there are other abnormal forms of tau that have not been found," she said. "After all, these are not even visible under the microscope."

And the same can be true of amyloid, Ashe said. "The important message here is that we need to known which forms of beta-amyloid and which forms of tau we want to target," she said.

More information

Find out more about advances in Alzheimer's research at the Alzheimer's Association.

Community programs get older people moving

Programs that increase older adults' exercise levels in the research setting can work in the real world as well, according to a new study.

Researchers found that two exercise programs that have proved effective in studies also worked when offered at the local YMCA or other community centers. Unlike traditional exercise classes, the programs taught older adults ways to change their behavior and fit physical activity into their daily lives. Overall, the study found, participants in each program bumped up their exercise levels, shed a few pounds and reported less stress and depression.

The findings are published in the July issue of the American Journal of Public Health.

Many studies have examined ways to ramp up older adults' exercise levels, but programs that work in a research setting do not necessarily translate to the real world. In the new study, researchers led by Dr. Sara Wilcox of the University of South Carolina in Columbia looked at whether two such programs are effective when offered by community centers, local health departments and health insurance plans. The study included 838 men and women age 50 and older who participated in one of the two interventions. One was a telephone-based program developed by Stanford University, in which counselors gave advice on breaking down barriers to exercise and safely fitting activity into daily life. The second program, developed by the Cooper Institute in Dallas, was similar but used group meetings instead of phone calls.

Through surveys before and after the programs, Wilcox and her colleagues found that participants increased their amount of moderate and vigorous exercise by more than 2 hours per week, on average.

At the same time, their depression and stress levels dipped, as did the groups' average weight. The findings, according to the researchers, show that exercise-promoting programs can be successfully moved from the lab to real life. "All too often," they note, "effective behavioral programs do not impact communities because they are never translated broadly."

 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.